Tocqueville Asset Management L.P. Has $24.01 Million Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Tocqueville Asset Management L.P. grew its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 307,046 shares of the company’s stock after acquiring an additional 1,084 shares during the period. Tocqueville Asset Management L.P. owned 0.07% of GE HealthCare Technologies worth $24,005,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Darwin Wealth Management LLC acquired a new stake in GE HealthCare Technologies in the third quarter valued at $31,000. Continuum Advisory LLC raised its stake in GE HealthCare Technologies by 101.8% in the third quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after buying an additional 168 shares during the period. Bank of Jackson Hole Trust acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at approximately $32,000. OFI Invest Asset Management bought a new position in shares of GE HealthCare Technologies during the 4th quarter worth approximately $34,000. Finally, Flagship Wealth Advisors LLC acquired a new position in shares of GE HealthCare Technologies during the 4th quarter worth approximately $34,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 0.6 %

Shares of GEHC stock opened at $82.47 on Tuesday. GE HealthCare Technologies Inc. has a fifty-two week low of $74.51 and a fifty-two week high of $94.80. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The stock has a 50 day simple moving average of $87.27 and a two-hundred day simple moving average of $86.12. The company has a market cap of $37.71 billion, a P/E ratio of 19.05, a PEG ratio of 3.19 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. Research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

Analysts Set New Price Targets

GEHC has been the topic of several research analyst reports. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price objective for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Citigroup boosted their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, February 13th. The Goldman Sachs Group raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and raised their price target for the stock from $85.00 to $100.00 in a research report on Tuesday, March 11th. Finally, Wells Fargo & Company raised their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and an average price target of $98.75.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.